Nonmydriatic Handheld Fundus Cameras Market

Nonmydriatic Handheld Fundus Cameras Market Outlook (2022-2026)

Expanding at a noteworthy CAGR of 8%, the global nonmydriatic handheld fundus cameras market is projected to increase from a valuation of US$ 140 million in 2022 to US$ 190 million by the end of 2026.

The ophthalmology clinics segment is also expected to expand at a CAGR of 8% from 2022 to 2026.

Report Attributes	Details
Nonmydriatic Handheld Fundus Cameras Market Size (2022E)	US$ 140 Million
Forecasted Market Value (2026F)	US$ 190 Million
Global Market Growth Rate (2022-2026)	8% CAGR
U.S. Market Value (2022)	US$ 42 Million
China Market Value (2026)	US$ 22 Million
Key Companies Profiled	Canon, Inc. Carl Zeiss Meditec AG Kowa Company Ltd. NIDEK Co., Ltd. Optomed Oy (Ltd.) Optovue Incorporated Topcon Corporation Veatch Ophthalmic Instruments

Nonmydriatic Handheld Fundus Camera Sales Analysis (2017-2021) Vs. Market Estimations (2022-2026)

In procedures such as fundus imaging, fluorescein angiography, paired optic disc pictures, and external photography, fundus cameras are most commonly employed.

The reflecting qualities of the retina are used by a non-mydriatic retinal camera to offer details and preserve images. Non-mydriatic fundus cameras produce better results than other devices such as slit lamps.

The camera aids in the early diagnosis and monitoring of numerous eye conditions, such as glaucoma, macular degeneration, and diabetic retinopathy. The camera is simple to use and the operator doesn't need any training.

The camera's advantages include a larger field of view and the availability of various filters for image improvement. Fundus photography involves taking a series of images of your eye's interior part through the pupil. Fundus cameras market size is expected to reach a valuation of US$ 640 million by 2026.

Hospitals and medical practices were impacted due to many modifications in the protocols during the COVID 19 epidemic. In this epidemic, ophthalmology procedures were also impacted.

Due to a decline in the number of patients with diabetic retinopathy and other vision issues being admitted to hospitals, the nonmydriatic handheld fundus cameras market was been impacted during the COVID-19 period.

According to Fact.MR, a market research and competitive intelligence provider, global nonmydriatic handheld fundus camera demand is currently valued at around US$ 140 million and is anticipated to surge at a CAGR of 8% through 2026.

What Aspects are Driving Market Share of Non-mydriatic Handheld Fundus Cameras?

“Rising Cases of Diabetic Retinopathy Augmenting Sales of Nonmydriatic Handheld Fundus Cameras”

A side effect of diabetes that damages the eyes is called diabetic retinopathy. The light-sensitive tissue in the rear of the eye's blood vessels gets harmed, due to this condition. Initially, diabetic retinopathy may not manifest any symptoms or may only result in minor vision issues.

Although the ideal DR screening method remains unknown, telemedicine is becoming more popular due to improvements in ophthalmic imaging and communication technologies.

While an in-person clinical examination by an eye care professional is the gold standard for diagnosing DR, mydriatic (dilated) 7-standard field stereoscopic 35-mm colour 30-degree retinal photographs that were developed from the Early Treatment Diabetic Retinopathy Study (ETDRS) are the standard for photographic detection and classification of DR.

The retinal tabletop camera systems utilized by the ETDRS are huge and difficult to transport. Both ease of use and camera portability are crucial factors when screening big populations. Hence, portable fundus cameras play an important role in imaging the retina of the eye.

“Increasing Age-related Macular Degeneration (AMD) Disorders Complementing Demand for Nonmydriatic Handheld Fundus Cameras”

The condition of age-related macular degeneration (AMD) also affects the retina. This takes place when the macula, a portion of the retina, is harmed.

AMD is a highly prevalent issue. It ranks among the top causes of vision loss in adults especially 50 years of age and older. In 2020, there were 196 million cases of macular degeneration in the world.

By 2040, that number is predicted to rise to 288 million. A nonmydriatic handheld fundus camera can be utilized to diagnose macular degeneration problems.

What is Negatively Affecting Revenue Growth of Suppliers of Non-mydriatic Handheld Fundus Cameras?

“High Cost of Fundus Cameras Denting Market Expansion to Some Extent”

The high cost of fundus cameras is expected to restrain the growth of the global market. The four main categories of fundus cameras in the market are retinopathy of prematurity (ROP), hybrid, mydriatic, and non-mydriatic cameras.

The most basic type of fundus camera is the mydriatic type, which is followed by the non-mydriatic fundus camera type. These tools serve as important diagnostic platforms for identifying retinal diseases such as glaucoma, AMD, and diabetic retinopathy.

Mydriatic fundus cameras can be purchased between US$ 10,000 and US$ 15,000, whereas non-mydriatic fundus cameras can be purchased between US$ 18,000 and US$ 22,000.

Which Factors Should Be Considered by New Market Players to Generate Higher Revenue Streams?

“Production of Improved Fundus Cameras – The Way Ahead”

One of the essential ocular technologies for imaging the retina and sub-retinal, which cover the inner surface of the eye, is fundus photography. Several eye conditions, including age-related macular degeneration, glaucoma, and diabetic retinopathy, can be diagnosed and monitored with fundus cameras.

Optometrists, ophthalmologists, and other qualified medical practitioners frequently employ fundus cameras. According to the diagnostic procedures, these gadgets are divided into mydriatic, non-mydriatic, and other fundus cameras.

Due to technological obsolescence, particularly concerning mydriatic fundus cameras, the global market for fundus cameras is extremely saturated.

Manufacturers of non-mydriatic handheld fundus cameras are concentrating on the creation of sturdy, high-performance fundus cameras with enhanced quality, with the creation of hybrid cameras being one of the ground-breaking innovations to emerge in recent years.

In comparison to different types of fundus photography, hybrid cameras combine optical coherence tomography (OCT) and fundus photography. Therefore, the market expansion will be accelerated by all of these changes in the coming years.

• To increase accessibility to reasonably priced eye care, Samsung announced the launch of the EYELIKE Fundus Camera in April 2021. Using a lens attachment and an AI algorithm on Samsung Galaxy devices, the EYELIKE fundus imaging system scans images for eye disorders. The company's portfolio of smartphone-based fundus cameras will be strengthened by this introduction.

Which Regions are Most Fruitful for Manufacturers of Non-mydriatic Handheld Fundus Cameras?

“Presence of Key Market Players & Rising Rate of Senior Population in North America”

The biggest geographical markets for nonmydriatic handheld fundus cameras are in North America and Europe.

The market for nonmydriatic handheld fundus cameras is expanding rapidly in North America as a result of the rising elderly population, the prevalence of diabetic retinopathy, and the quickening speed of technical development.

Another factor influencing the growth of the North America nonmydriatic handheld fundus cameras market is the introduction of sophisticated equipment in conjunction with the presence of significant enterprises in this region.

Another significant market for nonmydriatic portable fundus cameras is in Europe. Other causes of the rising use of fundus cameras in Europe include the high prevalence of AMD and the extensive use of cutting-edge medical technology.

Growing demand for nonmydriatic retinal cameras in the Asia Pacific is anticipated to increase significantly due to increased awareness and expanding healthcare infrastructure. A contributing element to the expansion of the fundus photography machines market in the Asia Pacific is developing healthcare facilities.

Country-wise Analysis

What is Supporting Nonmydriatic Handheld Fundus Cameras Market Growth in the United States?

“Continuous Technological Advancements & Rising Awareness of Eye Care”

In the United States, the market for nonmydriatic handheld fundus cameras is anticipated to reach US$ 42 million in 2022.

The market is being propelled by the continuous pace of technological development, rising awareness of eye care, rising elderly population, and supportive government efforts.

For instance, fundus imaging cameras should be updated every four years according to the laws and regulations of several medical device authorities in the United States. This helps in maintaining instrument performance and also enhances the diagnosis and therapy process.

Other elements driving the proliferation of nonmydriatic handheld fundus cameras are the adoption of digital technology and artificial intelligence.

How is China’s Market for Nonmydriatic Handheld Fundus Cameras Progressing?

“Rising Cases of Retinal & Ocular Disorders Fuelling Nonmydriatic Handheld Fundus Camera Demand”

The second-largest economy in the world, China, is predicted to reach a market size of US$ 22 million in 2026, due to the presence of key market players, availability of specialist services, and the expansion of medical tourism.

The market for non-mydriatic fundus cameras is also being driven by increased awareness of treating diabetic retinopathy and retinal and ocular diseases in this country.

Category-wise Analysis

Which Product Type is Gaining Immense Popularity?

“Non-mydriatic Fundus Cameras High in Demand Due to Non-dilation Aspect”

By the end of 2022, the non-mydriatic fundus cameras category is anticipated to hold the highest revenue share in the market. It enhances a practitioner's capacity to see intricate retinal anatomy that helps in eye disease diagnosis and treatment.

Fundus photography is considerably more patient-friendly since it uses non-mydriatic cameras rather than mydriatic ones, that don't require dilating drops or harsh lights. Furthermore, it also benefits glaucoma patients for whom dilation is not advised.

During the projection period, the market is expected to be driven by advancements in non-mydriatic cameras, including fluorescein imaging, mobility, and live-action systems.

Competitive Landscape

Major players operating in the global nonmydriatic handheld fundus camera market focus on obtaining regulatory clearances, developing technological cutting-edge products, innovating, and partnering & acquiring other businesses.

These tactics are probably going to help the market for nonmydriatic handheld fundus cameras expand worldwide. The following are a few expansion tactics used by companies competing in the worldwide fundus camera market :

• Pentacam AXL Wave was granted FDA 510(k) clearance by Oculus in March 2021. The most recent and versatile member of the Pentacam family is Pentacam AXL Wave, which includes network compatibility, easy reporting based on clinical research, and full operation of all Pentacam software and tests.

Segmentation of Nonmydriatic Handheld Fundus Cameras Industry Research

• By Type :

  • Non-mydriatic Fundus Cameras
  • Mydriatic Fundus Cameras
  • Hybrid Fundus Cameras

• By End User :

  • Hospitals
  • Ophthalmology Clinics
  • Ophthalmic & Optometrist Offices
  • Others

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA